The subject of this article is a protein designated "Recombinant Anopheles gambiae Cytosolic Fe-S cluster assembly factor NUBP1 homolog (AGAP011997)." This protein exists within the mosquito species Anopheles gambiae, a primary vector for malaria transmission in sub-Saharan Africa .
The protein is a homolog of the human NUBP1 protein, which is involved in cytosolic iron-sulfur (Fe-S) cluster assembly. Fe-S clusters are essential cofactors for a wide range of proteins involved in vital cellular processes such as electron transfer, enzymatic catalysis, and gene regulation. The Anopheles gambiae homolog (AGAP011997) likely plays a similar role in the mosquito, making it crucial for the mosquito's survival and development.
Understanding the function of AGAP011997 can provide insights into the mosquito's metabolism and potential vulnerabilities. Genetic manipulation of Anopheles gambiae can be achieved through various methods, including the use of transgenic mosquito Gal4 driver lines . These techniques can be employed to study the effects of altered gene expression on mosquito physiology and behavior .
Single amino acid differences can cause a wide range of structural and functional changes in proteins, including alterations in enzyme activity and binding affinity . For example, mutations can affect DNA bending or create cryptic mitochondrial targeting sequences . These genetic variations can have significant consequences for the organism's phenotype and adaptation.
Anopheles gambiae's capacity to adapt and thrive in diverse environments, including those impacted by human activity, has made it a persistent challenge for malaria control . Genomic surveillance projects aim to monitor and understand the genetic variations within Anopheles gambiae populations . Understanding the function of proteins like AGAP011997 can potentially identify new targets for intervention strategies aimed at disrupting mosquito development or reproduction.
Endosymbiotic bacteria, such as Wolbachia, can limit the infection of Anopheles mosquitoes with Plasmodium falciparum . Research has focused on the natural presence of transmission-blocking endosymbionts in Anopheles gambiae and Anopheles coluzzii . This highlights the complex interactions between mosquitoes, pathogens, and their associated microbiota, offering potential avenues for novel control strategies.
Anopheles gambiae Cytosolic Fe-S cluster assembly factor NUBP1 homolog (AGAP011997) is a component of the cytosolic iron-sulfur (Fe/S) protein assembly (CIA) machinery. It plays a crucial role in the maturation of extramitochondrial Fe-S proteins. The NUBP1-NUBP2 heterotetramer forms an Fe-S scaffold complex, facilitating de novo Fe-S cluster assembly and subsequent transfer to target apoproteins.
KEGG: aga:AgaP_AGAP011997
STRING: 7165.AGAP011997-PA
NUBP1 homolog in Anopheles gambiae functions as a critical component of the cytosolic iron-sulfur (Fe-S) protein assembly (CIA) machinery. Similar to other eukaryotic NUBP1 proteins, it is involved in the maturation of extramitochondrial Fe-S proteins, which are essential for various cellular processes. The protein belongs to the family of MRP/MinD-type P-loop NTPases with sequence similarity to bacterial division site-determining proteins .
The NUBP1 homolog in A. gambiae forms heterocomplexes with NUBP2, creating a scaffold for Fe-S cluster assembly. This heterotetramer mediates:
De novo assembly of Fe-S clusters
Transfer of assembled clusters to target apoproteins
Maintenance of cellular iron homeostasis
Research indicates that NUBP1 is conserved across eukaryotes, suggesting an evolutionarily essential function. In mosquitoes, proper function of this protein may influence cellular processes that impact vector competence and development .
Identification of NUBP1 homologs across species requires a systematic bioinformatic approach. The following methodology is recommended based on NCBI guidelines:
Step-by-step approach to identifying NUBP1 homologs:
Starting with the gene name:
If HomoloGene search is unsuccessful:
Using protein accession numbers:
Sequence-based homology search:
This methodology has successfully identified NUBP1 homologs across multiple species as demonstrated in the following table:
| Organism | Gene Symbol | Protein Accession |
|---|---|---|
| Homo sapiens (human) | NUBP1 | NP_002475.2 |
| Mus musculus (mouse) | Nubp1 | NP_036085.1 |
| Caenorhabditis elegans | F10G8.6 | NP_492653.2 |
| Drosophila melanogaster | CG17904 | NP_609805.1 |
| Anopheles gambiae | AGAP011997 | - |
| Saccharomyces cerevisiae | NBP35 | NP_011424.3 |
The high conservation of NUBP1 across species underscores its biological importance and provides valuable comparative models for functional studies .
Proper experimental controls are essential for accurate interpretation of results when working with recombinant NUBP1. Based on established protocols in molecular biology research, the following controls should be implemented:
Essential controls for recombinant NUBP1 experiments:
Expression system controls:
Functional assays:
Interaction studies:
RNAi experiments:
The importance of these controls is exemplified in studies of NUBP1 and NUBP2, where simultaneous knockdown experiments reveal synergistic effects that would be missed in single-gene studies. For instance, simultaneous double silencing of Nubp1 + KIFC5A was shown to restore the percentage of ciliated cells to control levels, highlighting complex functional interactions .
An optimal experimental design for studying NUBP1 function in Anopheles gambiae requires careful consideration of variables, controls, and measurement techniques. Based on current research methodologies, the following comprehensive experimental approach is recommended:
Experimental Design Framework:
Study objective definition:
Variable identification:
Experimental treatments:
Mosquito rearing conditions:
Sampling strategy:
Data collection procedures:
Data analysis plan:
Example of experimental timeline:
| Day | Experimental Procedure |
|---|---|
| 1 | Preparation of dsRNA targeting NUBP1 and control dsRNA |
| 3 | Microinjection of dsRNA into adult female mosquitoes |
| 5 | Blood feeding of injected mosquitoes |
| 8-12 | Collection of eggs and monitoring of larval development |
| 15-25 | Assessment of adult emergence rates and phenotypes |
| 26-30 | Molecular analysis of NUBP1 expression in different tissues |
| 30-35 | Vector competence assays through membrane feeding |
This experimental design incorporates robust controls and multiple assessment methods to comprehensively characterize NUBP1 function in A. gambiae .
RNA interference (RNAi) provides a powerful tool for investigating NUBP1 function in Anopheles gambiae. Based on successful studies in related organisms, the following methodological approach is recommended:
RNAi Methodology for NUBP1 Knockdown:
Target sequence selection:
dsRNA preparation:
Delivery methods:
Validation of knockdown:
Phenotype assessment:
The effectiveness of RNAi for studying NUBP1 is supported by research in C. elegans, where "RNAi-mediated silencing of nubp-1 causes the formation of morphologically aberrant and additional cilia in sensory neurons" . Similar approaches can be adapted for Anopheles gambiae, with appropriate modifications for species-specific delivery methods.
Expected phenotypes based on homologous systems:
Abnormal cilia formation
Altered development rates
Potential defects in iron metabolism
Genetic diversity in wild Anopheles gambiae populations significantly impacts NUBP1 research, necessitating consideration of natural variation when designing experiments and interpreting results. The Anopheles gambiae 1000 Genomes Project (Ag1000G) has revealed extensive genetic diversity that directly affects research approaches:
Impact of genetic diversity on NUBP1 research:
Sequence variation considerations:
Population structure implications:
Experimental design adjustments:
Sampling strategy:
Genetic validation:
Data interpretation considerations:
The Ag1000G project has sampled mosquitoes from at least 13 countries across Africa, revealing significant genetic diversity even within local populations . This diversity is summarized in the following table:
| Aspect of Genetic Diversity | Implication for NUBP1 Research |
|---|---|
| Local variation in effective population size | Differential selection pressure on NUBP1 |
| Recent selective sweeps in some populations | Possible hitchhiking effects on NUBP1 locus |
| Gene flow between species | Potential introgression of NUBP1 variants |
| Ancient population expansions | Deep ancestral variation in NUBP1 sequence |
Researchers must account for this genetic diversity when designing primers, probes, and reference sequences for NUBP1 studies, and should consider population genetic context when interpreting functional results .
Studying protein-protein interactions (PPIs) involving NUBP1 in Anopheles gambiae requires specialized techniques adapted to arthropod systems. Based on successful approaches with homologous proteins and mosquito studies, the following methodology is recommended:
Effective PPI techniques for NUBP1 research:
Co-immunoprecipitation (Co-IP):
Methodology:
Generate antibodies against A. gambiae NUBP1 or use epitope tags
Prepare mosquito tissue lysates under non-denaturing conditions
Immunoprecipitate NUBP1 and identify interacting partners by mass spectrometry
Advantages: Detects interactions in near-native conditions
Limitations: Requires high-quality antibodies or successful expression of tagged proteins
Yeast two-hybrid (Y2H) screening:
Methodology:
Clone NUBP1 into bait vector
Screen against A. gambiae cDNA library
Validate positive interactions with secondary assays
Advantages: High-throughput identification of binary interactions
Limitations: High false-positive rate; may miss interactions dependent on post-translational modifications
Bimolecular Fluorescence Complementation (BiFC):
Methodology:
Fuse NUBP1 and candidate partners to complementary fragments of fluorescent protein
Express in mosquito cell lines or tissues
Visualize interactions through fluorescence microscopy
Advantages: Visualizes interactions in living cells with spatial information
Limitations: Potential artificial stabilization of weak interactions
Proximity-dependent biotin identification (BioID):
Methodology:
Fuse NUBP1 to a promiscuous biotin ligase
Express in mosquito cells or tissues
Identify biotinylated proximity partners by pulldown and mass spectrometry
Advantages: Identifies transient interactions and nearby proteins in native cellular context
Limitations: Can identify proteins in proximity but not necessarily direct interactors
Based on studies with mammalian NUBP1, key interaction partners to investigate include:
| Protein Partner | Functional Significance | Recommended Detection Method |
|---|---|---|
| NUBP2 | Forms heterotetramer essential for Fe-S scaffold function | Co-IP, BiFC |
| KIFC5A | Minus-end directed motor protein involved in cilium formation | Y2H, Co-IP |
| CCT/TRiC complex members | Molecular chaperones enriched at basal body | BioID, Co-IP |
| CP110, CEP290 | Basal body proteins critical for ciliogenesis | BiFC, Co-IP |
Research has uncovered "novel interactions of Nubp1 with several members of the CCT/TRiC molecular chaperone complex, which... [are] enriched at the basal body" . Similar interactions are likely conserved in A. gambiae and represent promising research targets.
Effective data table design is crucial for clearly communicating NUBP1 research findings. Following established scientific guidelines for data presentation ensures clarity and facilitates interpretation:
Data table design principles for NUBP1 research:
Table structure fundamentals:
Include a clear, descriptive title that states the purpose of the experiment
Format: "The effect of ____ (independent variable) on ______ (dependent variable)"
Place independent variables in the left column
Place dependent variables and trial data in subsequent columns
Include a derived or calculated column (e.g., mean values) on the far right 15
Variable organization:
Statistical representation:
Example data table for NUBP1 knockdown experiments:
| Treatment | NUBP1 Expression (% of control) | Average Expression (%) | Phenotype Observation | ||
|---|---|---|---|---|---|
| Trial 1 | Trial 2 | Trial 3 | |||
| Control siRNA | 100.0 | 98.5 | 101.2 | 99.9 ± 1.4 | Normal cilia formation |
| NUBP1 siRNA 1 | 23.5 | 25.6 | 24.9 | 24.7 ± 1.1 | Increased ciliated cells |
| NUBP1 siRNA 2 | 18.7 | 20.1 | 19.3 | 19.4 ± 0.7 | Increased ciliated cells |
| NUBP1 + KIFC5A siRNA | 22.3 | 25.2 | 23.5 | 23.7 ± 1.5 | Normal ciliated cells |
Sample calculation: Average Expression (%) = (Trial 1 + Trial 2 + Trial 3) / 3
For Control siRNA: (100.0 + 98.5 + 101.2) / 3 = 99.9%
Advanced table design for complex experiments:
Remember that "in most cases, the independent variable (that which you purposefully change) is in the left column, the dependent variable (that which you measure) with the different trials is in the next columns, and the derived or calculated column (often average) is on the far right" .
Investigating NUBP1's potential role in vector competence requires specialized methodologies that bridge molecular biology and parasite transmission studies. The following comprehensive approach can effectively elucidate NUBP1's function in Plasmodium transmission:
Methodological framework for studying NUBP1 in vector competence:
Gene expression manipulation:
Direct membrane feeding assay (DMFA) protocol:
Preparation:
Maintain NUBP1-manipulated and control mosquito groups under identical conditions
Obtain Plasmodium-infected blood (P. falciparum gametocyte cultures or patient isolates)
Set up membrane feeders at 37°C
Feeding procedure:
Infection assessment:
Data collection and analysis:
Key metrics to measure:
Infection prevalence (% of mosquitoes infected)
Infection intensity (oocyst/sporozoite numbers per mosquito)
Transmission potential (sporozoite load in salivary glands)
Experimental setup example:
| Mosquito Group | Treatment | Number of Mosquitoes | Infection Prevalence (%) | Mean Oocyst Count | P-value |
|---|---|---|---|---|---|
| Control | Normal serum | 102 | 4.0 (4/102) | 1.2 ± 0.4 | - |
| Control | Serum replacement | 121 | 16.0 (19/121) | 3.5 ± 0.7 | <0.01 |
| NUBP1 KD | Normal serum | 45 | [?] | [?] | [?] |
| NUBP1 KD | Serum replacement | 112 | [?] | [?] | [?] |
This experimental design is based on successful approaches used in similar studies, where "the proportion of mosquitoes infected via direct membrane feeding assay with either P. malariae monoinfections (16% [19 of 121]) or coinfections (28% [31 of 112]) was higher after serum replacement than in parallel groups without serum replacement" .
Molecular mechanisms investigation:
This comprehensive methodology links molecular function to vector competence, providing insights into how NUBP1 might influence malaria transmission dynamics .
Optimizing heterologous expression systems for producing functional recombinant A. gambiae NUBP1 requires careful consideration of expression hosts, vectors, and purification strategies. Based on successful approaches with similar proteins, the following methodology is recommended:
Optimization strategy for recombinant A. gambiae NUBP1 expression:
Expression system selection:
E. coli:
Yeast (S. cerevisiae, P. pastoris):
Baculovirus/insect cells:
Mammalian cells:
Expression vector optimization:
Codon optimization:
Adjust codons for expression host (critical for AT-rich A. gambiae genes)
Remove rare codons and RNA secondary structures
Fusion tags selection:
Promoter selection:
Expression conditions optimization:
Temperature:
Lower temperatures (16-25°C) often improve folding
Test expression at 37°C, 30°C, 25°C, and 18°C
Induction parameters:
IPTG concentration: 0.1-1.0 mM for E. coli
Induction OD: Test early (OD600 0.4-0.6) vs. late (OD600 0.8-1.0)
Duration: 3-6h vs. overnight expression
Media supplements:
Purification strategy:
Initial capture:
IMAC (Ni-NTA) for His-tagged protein
Glutathione affinity for GST-fusion
Secondary purification:
Ion exchange chromatography
Size exclusion chromatography
Special considerations:
The choice of expression system significantly impacts yield and quality, as evidenced by commercial pricing: E. coli-expressed NUBP1 homolog costs approximately $930 for 0.02 mg, while mammalian cell-expressed protein is priced at $1,615 for the same amount, reflecting the increased complexity and biological relevance .